Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex vs Neostigmine for PPCs in Elderly Joint Surgery
NCT05040490Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Aug 2021
- Primary completion
- Jul 2022
- Modality
- Biodegradable Polymers, Small Molecules
01
Overview
Randomised, double-blind trial of Sugammadex in postoperative pulmonary complications (PPC) and Postoperative residual curarization (PORC), sponsored by Peking Union Medical College Hospital. Primary endpoint: Postoperative Pulmonary Complications at 30 days. Status: unknown.
02
Drugs
Sugammadex
03
Conditions
postoperative pulmonary complications (PPC)Postoperative residual curarization (PORC)
Beyond the preview
Go deeper on NCT05040490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05040490.